Characteristics of Advantages of Positron Emission Tomography over Computed Tomography for N-staging in Lung Cancer Patients
Open Access
- 26 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 36 (11), 694-698
- https://doi.org/10.1093/jjco/hyl092
Abstract
We analyzed the characteristics of advantages of positron emission tomography (PET) over computed tomography (CT) for N-staging in lung cancer patients. Preoperative PET and CT scans were performed for 2057 lymph node stations in 205 patients with peripheral-type lung cancer. The advantages of PET over CT for N-staging were analyzed among lymph node locations and histological subtypes. The pathological N-stages were N0 in 143 patients, N1 in 31, N2 in 24 and N3 in 7. PET was able to diagnose N0, N2 and N3 diseases more accurately than CT (P=0.03, 0.01 and 0.02, respectively), but there was no significant difference between the two modalities for N1 disease. In the upper mediastinal lymph node stations, both false-negative and false-positive were significantly less frequent with PET than with CT (P=0.001). In the lower mediastinal and supra clavicle lymph nodes, PET showed a lower frequency of false-negative than CT (P=0.04 and 0.003, respectively), but there was no significant difference in the frequency of false-positive between the two modalities. Among histological types, PET could stage adenocarcinoma with less frequent false-negative and squamous cell carcinoma with less frequent false-positive than CT (P=0.02 and 0.005, respectively). For N-staging, PET was superior to CT for the following: (1) more accurate for N0, N2 and N3 diseases but not for N1; (2) lower frequency of false-positive in the upper mediastinal nodes; and (3) lower frequencies of false-negative in adenocarcinoma and false-positive in squamous cell carcinoma. Recognizing these advantages of PET could make the N-staging of lung cancer more accurate.Keywords
This publication has 13 references indexed in Scilit:
- The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopyThe Annals of Thoracic Surgery, 2003
- Mediastinal Lymph Node Sampling Following Positron Emission Tomography With Fluorodeoxyglucose Imaging in Lung Cancer StagingChest, 2001
- Comparative Efficacy of Positron Emission Tomography With Fluorodeoxyglucose in Evaluation of Small (3 cm) Lymph Node LesionsChest, 2000
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Histological Typing of Lung and Pleural TumoursPublished by Springer Science and Business Media LLC ,1999
- Prospective investigation of positron emission tomography in lung nodules.Journal of Clinical Oncology, 1998
- Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancerEuropean Respiratory Journal, 1996
- Mediastinal staging of non-small-cell lung cancer with positron emission tomography.American Journal of Respiratory and Critical Care Medicine, 1995
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995